These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 29315813)

  • 21. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria.
    Fan HL; Chen TW; Hsieh CB; Jan HC; His SC; De-Chuan C; Chu CH; Yu JC
    Am J Surg; 2010 Aug; 200(2):252-7. PubMed ID: 20122677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.
    Koh JH; Tan DJH; Ong Y; Lim WH; Ng CH; Tay PWL; Yong JN; Muthiah MD; Tan EX; Pang NQ; Kim BK; Syn N; Kow A; Goh BKP; Huang DQ
    Hepatobiliary Surg Nutr; 2022 Feb; 11(1):78-93. PubMed ID: 35284509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
    Xiao GQ; Liu C; Liu DL; Yang JY; Yan LN
    World J Gastroenterol; 2013 Dec; 19(45):8398-407. PubMed ID: 24363533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.
    Seo CG; Yim SY; Um SH; Lee YR; Lee YJ; Kim TH; Goh HG; Lee YS; Suh SJ; Han NY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Kim JH; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):532-542. PubMed ID: 31870653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
    Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
    Lee SH; Lee JS; Na GH; You YK; Kim DG
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
    Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
    Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
    Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals.
    Krenzien F; Schmelzle M; Struecker B; Raschzok N; Benzing C; Jara M; Bahra M; Öllinger R; Sauer IM; Pascher A; Pratschke J; Andreou A
    J Gastrointest Surg; 2018 May; 22(5):840-848. PubMed ID: 29363019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.